Ophthalmology
2 drugs are in development for Cataract.
- Companies
- 2
- Clinical trials
- 13
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Cataract pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| dextenza | OCULAR THERAPEUTIX, INC (OCUL) |
Phase 3(1)
| Drug | Company |
|---|---|
| bimatoprost drug pad-iol system | SpyGlass Pharma Inc. (SGP) |
About this indication
Cataract context
Ophthalmology·MeSH: Cataract (D002386)
Also known as: Cataracts
Prevalence
1359.5 / 100K
Frequently asked questions
How many drugs are in development for Cataract?
BioSniper tracks 2 drugs in development for Cataract across 2 companies.
How many clinical trials target Cataract?
There are 13 clinical trials targeting Cataract tracked by BioSniper.
What is the prevalence of Cataract?
The estimated prevalence of Cataract is approximately 1359.5 per 100,000 population.